Augmented Reality to Support Cardiopulmonary Resuscitation
Key facts
- Who runs it
- Johan Siebert, MD
- Where
- Canada and Switzerland2 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 54 people enrolled
- Started
- 2 Apr 2025
- Ended
- 1 Jul 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Augmented reality supportive tool
- Conventional method (AHA pocket reference card)
- Record updated
- 19 August 2025
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Inclusion criteria for the team leader include: attending physician, fellow, or senior resident in emergency medicine, pediatric emergency medicine, pediatrics, pediatric critical care, or pediatric anesthesia
- Inclusion criteria for the medication and charting nurse roles include: nurse in pediatric emergency medicine, general pediatrics, or other pediatric acute care specialty
- Inclusion criteria for all other team members include: pediatric attending physician, resident, fellow, nurse or respiratory therapist
- Participants must have prior basic life support training
- Participation agreement
Who cannot take part
- Previously enrolled
- Decline to provide informed consent
- Unable to perform tasks required of the role
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
A prospective, multicenter, randomized clinical trial in two tertiary pediatric emergency department. It will assess, amongst pediatric healthcare teams, whether the use of augmented reality supportive devices improves adherence to American Heart Association (AHA) advanced life support guidelines and performance, while reducing medication errors, when compared to groups using the AHA pocket reference card (control) during standardized, simulation-based, pediatric in-hospital cardiac arrest (IHCA) scenarios. Seventy participants will be randomized. The primary endpoint is the time to first dose of epinephrine.
The 2 groups in the trial
- Arm A (Augmented Reality)Treatment being tested
Participants that will use the augmented reality supportive tool during the simulation-based pediatric scenario.
Treatment: Augmented reality supportive tool
- Arm B (Conventional methods)Existing treatment, for comparison
Participants that will use conventional methods during the simulation-based pediatric scenario.
Treatment: Conventional method (AHA pocket reference card)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of an Augmented Reality and Screen-based Decision Support System for Cardiopulmonary Arrest: a Multicenter, Randomized Clinical Trial
- Publications
- Distribution of visual attention amongst clinicians using an augmented reality-based decision support system during simulated cardiac arrest - A descriptive study.Resuscitation plus, 2026
- Augmented Reality-Guided Decision Support in Simulated Pediatric Cardiac Arrest: A Randomized Clinical Trial.JAMA network open, 2026
- Impact of an augmented reality-based decision support system on teamwork, leadership, provider workload and cognitive load during simulated cardiac arrest - a simulation-based randomized controlled trial.Advances in simulation (London, England), 2026
- Record updated
- 19 August 2025